Xinmei Zhu1, John P Pribis, Paulo C Rodriguez, Sidney M Morris, Yoram Vodovotz, Timothy R Billiar, Juan B Ochoa. 1. Departments of *Surgery †Departments of Microbiology, Immunology, and Parasitology, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA. ‡Immunology §Microbiology and Molecular Genetics ¶Critical Care Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA; and ‖Center for Inflammation and Regenerative Modeling, McGowan Institute for Regenerative Medicine.
Abstract
OBJECTIVE: To explore the hypothesis that decreased arginine availability by myeloid-derived suppressor cells (MDSCs) is a cause of T-cell dysfunction after physical injury (PI). BACKGROUND: Arginine is an essential amino acid for normal T-cell function whose availability becomes limited after PI. MDSCs expressing arginase 1 are induced by PI. T-cell dysfunction after PI seems to increase the risk of infection but the mechanisms that cause it are unclear. METHODS: PI was created using a standard laparotomy model. Phenotypical and functional alterations in T cells were evaluated in vivo. MDSCs expressing arginase 1 were measured by flow cytometry. Infection after PI was created by intraperitoneal injection of Listeria monocytogenes. N-Hydroxy-Nor-L-arginine (Nor-NOHA) was used as an arginase inhibitor. The effect of arginine depletion on T-cell function and susceptibility to infection was assessed through adoptive transfer of MDSC or injection of arginase into noninjured mice. RESULTS: PI caused a decrease in intracellular arginine in T cells, loss of the T-cell receptor (TCR) CD3-ζ chain, inhibition of in vivo T-cell proliferation, memory, and cytotoxicity. PI exponentially increased bacterial growth and mortality to L. monocytogenes. T-cell dysfunction and increased infection were reversed by arginase inhibitor Nor-NOHA but were reproduced by adoptively transferring MDSC or injecting arginase 1 to noninjured mice. CONCLUSIONS: Arginine availability is decreased after PI coinciding with an induction of MDSC expressing arginase 1. Decreased arginine may inhibit T-cell function and increase susceptibility to infection after injury.
OBJECTIVE: To explore the hypothesis that decreased arginine availability by myeloid-derived suppressor cells (MDSCs) is a cause of T-cell dysfunction after physical injury (PI). BACKGROUND:Arginine is an essential amino acid for normal T-cell function whose availability becomes limited after PI. MDSCs expressing arginase 1 are induced by PI. T-cell dysfunction after PI seems to increase the risk of infection but the mechanisms that cause it are unclear. METHODS: PI was created using a standard laparotomy model. Phenotypical and functional alterations in T cells were evaluated in vivo. MDSCs expressing arginase 1 were measured by flow cytometry. Infection after PI was created by intraperitoneal injection of Listeria monocytogenes. N-Hydroxy-Nor-L-arginine (Nor-NOHA) was used as an arginase inhibitor. The effect of arginine depletion on T-cell function and susceptibility to infection was assessed through adoptive transfer of MDSC or injection of arginase into noninjured mice. RESULTS: PI caused a decrease in intracellular arginine in T cells, loss of the T-cell receptor (TCR) CD3-ζ chain, inhibition of in vivo T-cell proliferation, memory, and cytotoxicity. PI exponentially increased bacterial growth and mortality to L. monocytogenes. T-cell dysfunction and increased infection were reversed by arginase inhibitor Nor-NOHA but were reproduced by adoptively transferring MDSC or injecting arginase 1 to noninjured mice. CONCLUSIONS:Arginine availability is decreased after PI coinciding with an induction of MDSC expressing arginase 1. Decreased arginine may inhibit T-cell function and increase susceptibility to infection after injury.
Authors: Brittany Mathias; Amber L Delmas; Tezcan Ozrazgat-Baslanti; Erin L Vanzant; Benjamin E Szpila; Alicia M Mohr; Frederick A Moore; Scott C Brakenridge; Babette A Brumback; Lyle L Moldawer; Philip A Efron Journal: Ann Surg Date: 2017-04 Impact factor: 12.969
Authors: Miguel Ángel Palomero Rodríguez; Rósula García Navas; Yolanda Laporta Báez; Jesús de Vicente Sánchez; Jose Carlos Moyano Maza; Jose María Rodríguez López; Maria Pilar Sánchez Conde; Faustino Mollinedo Journal: Intensive Care Med Date: 2015-03-05 Impact factor: 17.440
Authors: Lucas W Thornblade; Thomas K Varghese; Xu Shi; Eric K Johnson; Amir Bastawrous; Richard P Billingham; Richard Thirlby; Alessandro Fichera; David R Flum Journal: Dis Colon Rectum Date: 2017-01 Impact factor: 4.585
Authors: Cortney E Heim; Debbie Vidlak; Jessica Odvody; Curtis W Hartman; Kevin L Garvin; Tammy Kielian Journal: J Orthop Res Date: 2017-12-05 Impact factor: 3.494
Authors: Matthew Fletcher; Maria E Ramirez; Rosa A Sierra; Patrick Raber; Paul Thevenot; Amir A Al-Khami; Dulfary Sanchez-Pino; Claudia Hernandez; Dorota D Wyczechowska; Augusto C Ochoa; Paulo C Rodriguez Journal: Cancer Res Date: 2014-11-18 Impact factor: 12.701
Authors: Martin D Rosenthal; Amir Y Kamel; Cameron M Rosenthal; Scott Brakenridge; Chasen A Croft; Frederick A Moore Journal: Nutr Clin Pract Date: 2018-01-11 Impact factor: 3.080
Authors: Lee-Hwa Tai; Almohanad A Alkayyal; Amanda L Leslie; Shalini Sahi; Sean Bennett; Christiano Tanese de Souza; Katherine Baxter; Leonard Angka; Rebecca Xu; Michael A Kennedy; Rebecca C Auer Journal: Oncoimmunology Date: 2018-03-01 Impact factor: 8.110